NINGBO INNO PHARMCHEM CO.,LTD. is at the forefront of supplying high-quality chemical compounds essential for scientific advancement, including (3-Carboxypropyl)triphenylphosphonium Bromide (CAS 17857-14-6). This compound is gaining increasing recognition for its diverse applications, serving as both a critical pharmaceutical intermediate and a potent mitochondrial targeting reagent. Its unique properties make it invaluable for a wide range of research and development activities.

The integrity of scientific research hinges on the quality of the materials used. The precise synthesis of 3-carboxypropyl triphenylphosphonium bromide by NINGBO INNO PHARMCHEM CO.,LTD. guarantees a product of exceptional purity and consistency, ensuring reliable and reproducible results for researchers. As a key supplier of CAS 17857-14-6 pharmaceutical intermediate, we are committed to upholding the highest standards, enabling the seamless progression of drug discovery and development projects.

The utility of (3-Carboxypropyl)triphenylphosphonium Bromide as a mitochondrial targeting reagent is particularly noteworthy. This capability is critical for studies investigating cellular metabolism, the mechanisms of diseases linked to mitochondrial dysfunction, and the development of novel therapeutic strategies. By enabling targeted delivery to mitochondria, this compound facilitates deeper insights into cellular biology and opens new avenues for effective treatments.

Furthermore, this phosphonium salt is instrumental as a precursor in the synthesis of sphingosine 1-phosphate-1 receptor antagonists. These compounds are of significant therapeutic interest, and the reliable availability of this essential building block is crucial for advancing their development. NINGBO INNO PHARMCHEM CO.,LTD. ensures that researchers can readily buy chemical reagents like this vital pharmaceutical intermediate, thereby supporting innovation in medicinal chemistry. Our contribution helps bridge the gap between laboratory research and potential clinical applications, driving progress in healthcare.